4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-066821
President and CEO gave up 1,811 shares (to pay taxes)
- President and CEO acquired 5,958 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Walker Neal · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-12-15 | Exercise or conversion : show line 1 in the form | +3,033 | 877,052 | D | ||
| 2017-12-15 | Shares withheld for taxes : show line 2 in the form | −922 | $24.23 | $22,340 | 876,130 | D |
| 2017-12-18 | Exercise or conversion : show line 3 in the form | +2,925 | 879,055 | D | ||
| 2017-12-18 | Shares withheld for taxes : show line 4 in the form | −889 | $24.12 | $21,443 | 878,166 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-12-15 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −3,033 | 21,233 | D |
| 2017-12-18 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −2,925 | 5,850 | D |
Loading xslF345X03/doc4.xml…